Walleye Capital’s SBC Medical Group SBC Stock Holding History

Walleye Capital’s Portfolio SBC Stock Details SBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-86,054	Closed	-$1.12M	–	5985
2024 Q2	$1.12M	Sell	86,054 -39,258	-31%	-$526K	﹤0.01%	2719
2024 Q1	$1.59M	Sell	125,312 -18,752	-13%	-$215K	﹤0.01%	2164
2023 Q4	$1.55M	Hold	144,064	–	–	﹤0.01%	1987
2023 Q3	$1.54M	Hold	144,064	–	–	﹤0.01%	1928
2023 Q2	$1.48M	Buy	+144,064	New	+$1.49M	0.01%	1540

Other funds holding SBC

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TCM

Tuttle Capital Management Riverside, Connecticut $148M AUM 64.07% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Walleye Capital's SBC Position: Q3 2024 in Review

Walleye Capital sold out of SBC Medical Group (SBC) in Q3 2024, closing a stake of 86,054 shares — an estimated $1.12M sold.

Walleye Capital first reported a position in SBC in Q2 2023 and held it in 5 quarters. The position peaked at $1.59M in Q1 2024. 3 funds tracked by Wall St. Rank hold SBC as of Q3 2024.

Walleye Capital reported no remaining SBC Medical Group position as of Q3 2024 after selling out during the quarter.
Walleye Capital sold 86,054 SBC Medical Group shares in Q3 2024, an estimated $1.12M.
Walleye Capital first reported a position in SBC Medical Group in Q2 2023 and held it in 5 quarters.
Walleye Capital's SBC Medical Group position peaked at $1.59M in Q1 2024.
3 funds tracked by Wall St. Rank held SBC Medical Group as of Q3 2024.

Based on Walleye Capital's 13F filing for Q3 2024, filed 14 Nov 2024.